Clinical Trials List
2021-03-02 - 2024-06-16
Phase II
Terminated5
-
Trial Applicant
National Health Research Institutes
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 陳盛裕 Division of Hematology & Oncology
- Chueh-Chuan Yen 醫學研究部
- Yi-Ping Hung Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- Sheng-Yu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chi-Ting Liau Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- Hsien-Kun Chang Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Wei-Lun Chang Digestive System Department
- 姜乃榕 Division of Hematology & Oncology
- Kwang-Yu Chang Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- Nai-Jung Chiang Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wang Yao-Kuang Digestive System Department
- 高育青 Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Wen-Hung Hsu Digestive System Department
- Tsung-Jang Yeh Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
48 participants
-
Global
48 participants